Codexis (CDXS)
(Delayed Data from NSDQ)
$2.69 USD
+0.01 (0.37%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.68 -0.01 (-0.37%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Codexis, Inc. has a market cap of $222.02M, which represents its share price of $2.68 multiplied by its outstanding shares number of 82.85M. As a small-cap company, CDXS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CDXS 2.69 +0.01(0.37%)
Will CDXS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CDXS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDXS
Regeneron (REGN) Tops Q2 Earnings and Revenue Estimates
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates
CDXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Dare Bioscience, Inc. (DARE) Reports Q1 Loss, Lags Revenue Estimates
Immunome, Inc. (IMNM) Reports Q1 Loss, Tops Revenue Estimates
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy?
Other News for CDXS
Codexis to Report Second Quarter 2025 Financial Results on August 13 | CDXS Stock News
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Opaleye Management Inc. Increases Stake in Codexis Inc.
Opaleye Management Makes a Bold Move with Codexis Stock Purchase!